AAVion®

From plasmid design to vial-ready product, our proprietary AAVion® platform streamlines every step—upstream production, purification, fill & finish, analytics, and QP release — to accelerate your AAV program toward clinical success.

As a global CDMO, we are dedicated to advancing biologics and life-transforming therapies, supporting partners from early development through commercialization. Our comprehensive services span microbial and mammalian protein expression, viral vector production for AAV and adenovirus, cell therapy, plasmid DNA manufacturing, and aseptic fill & finish to ensure seamless, end-to-end GMP manufacturing.